The inclusion of ESR1 as a hub gene suggests that MQLEO may interfere with estrogen receptor signaling, potentially attenuating oncogenic pathways such as MAPK/ERK or PI3K/AKT, which are frequently dysregulated in lung cancer [63,64]. This evidence concerns the gene ESR1 and lung carcinoma.